fig4
Figure 4. (A) Schematic illustration of the fabrication of M1-Exos and AApt-Lips hybrid nanovesicles and their regulated anticancer treatment; (B) In vivo antitumor effects of M1-Exos and AApt-Lips hybrid nanovesicles [reproduced with permission from Zhen et al. (2024)[134]. Copyright 2024 John Wiley and Sons]. M1-Exos: M1 macrophages-derived exosomes.
